Conmed (CNMD) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $47.14, +4.92% vs the prior close of $44.93.
- Volume 401.30K shares, 1.1x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
CNMD jumps 4.9% to $47.14. Closed at $47.14, +4.92% vs the prior close of $44.93. Day range $44.89–$47.85, opened at $45.59.
CNMD daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — CNMD jumps 4.9% to $47.14
- Closed at $47.14, +4.92% vs the prior close of $44.93. Day range $44.89–$47.85, opened at $45.59.
- Volume was 401.30K shares, 1.1x its 50-day average of 349.28K.
- Price is -1.2% vs its 50-day average ($47.72) and +14.6% vs its 200-day average ($41.14).
- 52-week range $31.44–$53.66; today's close sits at 71% of that range, 12.2% below the 52-week high.
Oct 14, 2026 — CNMD dips 1.4% to $44.93
- Closed at $44.93, -1.36% vs the prior close of $45.55. Day range $44.53–$46.59, opened at $45.23.
- Volume was 392.40K shares, 1.1x its 50-day average of 352.66K.
- Price is -5.9% vs its 50-day average ($47.76) and +9.3% vs its 200-day average ($41.11).
- 52-week range $31.44–$53.66; today's close sits at 61% of that range, 16.3% below the 52-week high.
Oct 13, 2026 — CNMD rises 0.4% to $45.55
- Closed at $45.55, +0.42% vs the prior close of $45.36. Day range $44.09–$46.09, opened at $45.59.
- Volume was 521.70K shares, 1.4x its 50-day average of 366.17K.
- Price is -4.8% vs its 50-day average ($47.87) and +10.8% vs its 200-day average ($41.09).
- 52-week range $31.44–$53.66; today's close sits at 64% of that range, 15.1% below the 52-week high.
Oct 12, 2026 — CNMD rises 2.1% to $45.36
- Closed at $45.36, +2.12% vs the prior close of $44.42. Day range $44.18–$45.45, opened at $44.96.
- Volume was 515.20K shares, 1.4x its 50-day average of 368.70K.
- Price is -5.5% vs its 50-day average ($47.99) and +10.5% vs its 200-day average ($41.07).
- 52-week range $31.44–$53.66; today's close sits at 63% of that range, 15.5% below the 52-week high.
Oct 9, 2026 — CNMD dips 1.5% to $44.42
- Closed at $44.42, -1.53% vs the prior close of $45.11. Day range $44.15–$45.66, opened at $44.89.
- Volume was 400.40K shares, 1.1x its 50-day average of 377.70K.
- Price is -7.5% vs its 50-day average ($48.01) and +8.2% vs its 200-day average ($41.04).
- 52-week range $31.44–$53.66; today's close sits at 58% of that range, 17.2% below the 52-week high.
Oct 8, 2026 — CNMD rises 2.0% to $45.11
- Closed at $45.11, +1.99% vs the prior close of $44.23. Day range $44.05–$45.43, opened at $44.32.
- Volume was 474.00K shares, 1.2x its 50-day average of 383.47K.
- Price is -6.1% vs its 50-day average ($48.06) and +10.0% vs its 200-day average ($41.02).
- 52-week range $31.44–$53.66; today's close sits at 62% of that range, 15.9% below the 52-week high.
Oct 7, 2026 — CNMD dips 0.6% to $44.23, a 1-month low
- Closed at $44.23, -0.56% vs the prior close of $44.48. Day range $43.97–$44.64, opened at $44.07.
- Volume was 521.30K shares, 1.3x its 50-day average of 388.30K.
- Price is -7.9% vs its 50-day average ($48.03) and +7.9% vs its 200-day average ($40.99).
- 52-week range $31.44–$53.66; today's close sits at 58% of that range, 17.6% below the 52-week high.
Oct 6, 2026 — CNMD slides 6.0% to $44.48, a 1-month low
- Closed at $44.48, -6.02% vs the prior close of $47.33. Day range $44.31–$48.25, opened at $47.83.
- Volume was 456.40K shares, 1.2x its 50-day average of 387.92K.
- Price is -7.4% vs its 50-day average ($48.03) and +8.6% vs its 200-day average ($40.97).
- 52-week range $31.44–$53.66; today's close sits at 59% of that range, 17.1% below the 52-week high.
Oct 5, 2026 — CNMD rises 2.2% to $47.33
- Closed at $47.33, +2.18% vs the prior close of $46.32. Day range $46.11–$47.77, opened at $46.43.
- Volume was 343.30K shares, 0.9x its 50-day average of 389.75K.
- Price is -1.4% vs its 50-day average ($48.01) and +15.6% vs its 200-day average ($40.95).
- 52-week range $31.44–$53.66; today's close sits at 72% of that range, 11.8% below the 52-week high.
Oct 2, 2026 — CNMD rises 0.8% to $46.32
- Closed at $46.32, +0.85% vs the prior close of $45.93. Day range $46.16–$47.06, opened at $46.88.
- Volume was 240.70K shares, 0.6x its 50-day average of 398.75K.
- Price is -3.3% vs its 50-day average ($47.91) and +13.2% vs its 200-day average ($40.91).
- 52-week range $31.44–$53.66; today's close sits at 67% of that range, 13.7% below the 52-week high.
CNMD latest news & SEC filings
Every SEC filing by or about CNMD in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Sep 10, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 29, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Revenue: $343.49M (prior year $342.35M) (+0.3% vs Jun 30, 2025)
- Net income: $23.07M (prior year $21.42M) (+7.7% vs Jun 30, 2025)
- Diluted EPS: $0.77 (prior year $0.69) (+11.6% vs Jun 30, 2025)
Jul 29, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 17, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 17, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jul 2, 2026 · Form 3 — New insider holdings
Initial insider ownership statement (Form 3) — a new director, officer or 10% owner disclosed their holdings
Things to know before you trade CNMD
- Last results release: Jul 29, 2026 (8-K Item 2.02). Previous ones: Apr 29, 2026, Jan 28, 2026, Nov 5, 2025. Based on that rhythm, the next report is likely around Oct 28, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.78% (largest 6.0%).
- Liquidity: about 399.86K shares (≈$18.85M) trade per day on average.
- 52-week position: $47.14 vs a range of $31.44–$53.66 (71% of the range).
- Dividends: last ex-dividend date Sep 15, 2025 ($0.2/share); 0 payments in the past 12 months.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 2 sales; latest: Richard Glaze sold 257 shares on Nov 21, 2025.
- Latest filings: 10-Q Jul 29, 2026; 8-K Jul 29, 2026; 8-K Jun 17, 2026.
- Share count: 29.95M shares outstanding (Jul 27, 2026), -3.2% vs a year earlier — the company has been reducing its share count.
- Listing: NYSE · industry: Electromedical & Electrotherapeutic Apparatus.
CNMD market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 45.59 | 47.85 | 44.89 | 47.14 | 401.30K |
| Oct 14, 2026 | 45.23 | 46.59 | 44.53 | 44.93 | 392.40K |
| Oct 13, 2026 | 45.59 | 46.09 | 44.09 | 45.55 | 521.70K |
| Oct 12, 2026 | 44.96 | 45.45 | 44.18 | 45.36 | 515.20K |
| Oct 9, 2026 | 44.89 | 45.66 | 44.15 | 44.42 | 400.40K |
| Oct 8, 2026 | 44.32 | 45.43 | 44.05 | 45.11 | 474.00K |
| Oct 7, 2026 | 44.07 | 44.64 | 43.97 | 44.23 | 521.30K |
| Oct 6, 2026 | 47.83 | 48.25 | 44.31 | 44.48 | 456.40K |
| Oct 5, 2026 | 46.43 | 47.77 | 46.11 | 47.33 | 343.30K |
| Oct 2, 2026 | 46.88 | 47.06 | 46.16 | 46.32 | 240.70K |
| Oct 1, 2026 | 46.18 | 46.59 | 45.73 | 45.93 | 222.40K |
| Sep 30, 2026 | 46.66 | 47.18 | 46.17 | 46.23 | 290.10K |
| Sep 29, 2026 | 46.31 | 46.79 | 45.25 | 46.69 | 229.00K |
| Sep 28, 2026 | 44.91 | 46.75 | 44.50 | 46.48 | 374.80K |
| Sep 25, 2026 | 45.30 | 46.51 | 45.10 | 45.38 | 282.60K |
| Sep 24, 2026 | 45.59 | 45.95 | 44.79 | 45.18 | 263.30K |
| Sep 23, 2026 | 45.48 | 46.15 | 44.75 | 45.80 | 491.20K |
| Sep 22, 2026 | 45.37 | 46.55 | 45.22 | 46.17 | 441.80K |
| Sep 21, 2026 | 45.82 | 45.83 | 44.39 | 44.69 | 354.70K |
| Sep 18, 2026 | 45.73 | 46.13 | 45.10 | 45.42 | 780.50K |
About Conmed
Conmed (CNMD) is listed on the NYSE and classified by the SEC under “Electromedical & Electrotherapeutic Apparatus”. Its business address is in LARGO, FL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 816956.
CNMD board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| David M. Bronson | Director | Jun 3, 2026 |
| Laverne H Council | Director | Jun 3, 2026 |
| Charles Farkas | Director | Jun 3, 2026 |
| Mark Kaye | Director | Jun 3, 2026 |
| Kim Kelderman | Director | Sep 10, 2026 |
| Celine Christine Martin | Director | Jul 2, 2026 |
| Jeffrey B. Mirviss | Director | Jul 2, 2026 |
| Barbara J Schwarzentraub | Director | Jun 3, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Pat Beyer | President & CEO | Apr 2, 2026 |
| John D. Ferrell | Executive Vice President - HR | Mar 18, 2026 |
| Hollie K Foust | General Counsel & Corp Sec | Mar 18, 2026 |
| John E Gallagher | Executive Vice President & CFO | Jul 17, 2026 |
| Todd W Garner | Executive Vice President & CFO | Nov 7, 2025 |
| Richard Glaze | Chief Information Officer | Nov 24, 2025 |
| Brent Lalomia | Executive VP RA, QA | Mar 18, 2026 |
| Kimberly Lockwood | Interim Corp Controller & PFO | Jun 3, 2026 |
| Andrew James Moller | VP Corporate Controller | Mar 4, 2026 |
| Johonna Marie Pelletier | Treasurer and VP, Tax | Mar 4, 2026 |
| Peter K Shagory | EVP, STRAT & CORP DEVT | Mar 18, 2026 |
| Matthew Schabacker | VP GM Advanced Surgical | Mar 18, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Nov 21, 2025 | Richard Glaze | Sale | 257 | $41.21 |
| Nov 6, 2025 | Todd W Garner | Sale | 3,500 | $43.00 |
CNMD financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $1.37B | $47.05M | 1.51 | $170.69M |
| Dec 31, 2024 | $1.31B | $132.42M | 4.25 | $166.97M |
| Dec 31, 2023 | $1.24B | $64.46M | 2.04 | $125.35M |
| Dec 31, 2022 | $1.05B | $-80.58M | -2.68 | $33.37M |
| Dec 31, 2021 | $1.01B | $62.54M | 1.94 | $111.77M |
Latest balance sheet: total assets $2.30B, total liabilities $1.26B, cash $25.86M (as of Jun 30, 2026).
CNMD earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Jul 29, 2026 | 8-K Item 2.02 (results) | $43.21 |
| Apr 29, 2026 | 8-K Item 2.02 (results) | $35.96 |
| Jan 28, 2026 | 8-K Item 2.02 (results) | $38.69 |
| Nov 5, 2025 | 8-K Item 2.02 (results) | $44.44 |
| Jul 30, 2025 | 8-K Item 2.02 (results) | $50.14 |
| Apr 30, 2025 | 8-K Item 2.02 (results) | $49.11 |
| Feb 5, 2025 | 8-K Item 2.02 (results) | $74.00 |
| Oct 30, 2024 | 8-K Item 2.02 (results) | $65.26 |
| Oct 4, 2024 | 8-K Item 2.02 (results) | — |
| Jul 31, 2024 | 8-K Item 2.02 (results) | — |
| Apr 24, 2024 | 8-K Item 2.02 (results) | — |
| Jan 31, 2024 | 8-K Item 2.02 (results) | — |
Related stocks · Electromedical & Electrotherapeutic Apparatus
Medtronic (MDT)TransMedics (TMDX)Integer (ITGR)LivaNova (LIVN)Axogen (AXGN)Ceribell (CBLL)InMode (INMD)Neuraxis (NRXS)Electromed (ELMD)CapsoVision (CV)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on CNMD
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.